Dustin S. Sjuts - 09 Nov 2021 Form 4 Insider Report for Revance Therapeutics, Inc.

Role
President
Signature
/s/ Gordon Ho, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Nov 2021
Net transactions value
$0
Form type
4
Filing time
10 Nov 2021, 19:32:26 UTC
Previous filing
02 Jul 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Award $0 +35,920 +54% $0.000000 101,900 09 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from December 15, 2021, subject to Mr. Sjuts' Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.